Global Antisense Oligonucleotides Market 2023 by Company, Regions, Type and Application, Forecast to 2029
Antisense oligonucleotides (ASOs) are 15–25 nt oligonucleotides designed to tie complementary RNA targets for the degradation. They are synthesized so that they can be used to block disease processes by altering the synthesis of a specific protein.
According to our (Global Info Research) latest study, the global Antisense Oligonucleotides market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Antisense Oligonucleotides market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Antisense Oligonucleotides market size and forecasts, in consumption value ($ Million), 2018-2029
Global Antisense Oligonucleotides market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Antisense Oligonucleotides market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Antisense Oligonucleotides market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Antisense Oligonucleotides
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Antisense Oligonucleotides market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ionis Pharmaceuticals, Sarepta Therapeutics, Biogen, Alnylam Pharmaceuticals and Antisense Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Antisense Oligonucleotides market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Antisense Oligonucleotides product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Antisense Oligonucleotides, with revenue, gross margin and global market share of Antisense Oligonucleotides from 2018 to 2023.
Chapter 3, the Antisense Oligonucleotides competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Antisense Oligonucleotides market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Antisense Oligonucleotides.
Chapter 13, to describe Antisense Oligonucleotides research findings and conclusion.
According to our (Global Info Research) latest study, the global Antisense Oligonucleotides market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Antisense Oligonucleotides market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Antisense Oligonucleotides market size and forecasts, in consumption value ($ Million), 2018-2029
Global Antisense Oligonucleotides market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Antisense Oligonucleotides market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Antisense Oligonucleotides market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Antisense Oligonucleotides
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Antisense Oligonucleotides market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ionis Pharmaceuticals, Sarepta Therapeutics, Biogen, Alnylam Pharmaceuticals and Antisense Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Antisense Oligonucleotides market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- RNA Antisense Oligonucleotides
- DNA Antisense Oligonucleotides
- Hospitals
- Clinic
- Others
- Ionis Pharmaceuticals
- Sarepta Therapeutics
- Biogen
- Alnylam Pharmaceuticals
- Antisense Therapeutics
- Isarna Therapeutics
- Arrowhead Pharmaceuticals
- Atlantic Pharmaceuticals
- Enzon Pharmaceuticals
- Bio-Path Holdings
- GlaxoSmithKline
- Geron
- ICO Therapeutics
- Marina Biotech
- RXi Pharmaceuticals
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Antisense Oligonucleotides product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Antisense Oligonucleotides, with revenue, gross margin and global market share of Antisense Oligonucleotides from 2018 to 2023.
Chapter 3, the Antisense Oligonucleotides competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Antisense Oligonucleotides market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Antisense Oligonucleotides.
Chapter 13, to describe Antisense Oligonucleotides research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Antisense Oligonucleotides
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Antisense Oligonucleotides by Type
1.3.1 Overview: Global Antisense Oligonucleotides Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Antisense Oligonucleotides Consumption Value Market Share by Type in 2022
1.3.3 RNA Antisense Oligonucleotides
1.3.4 DNA Antisense Oligonucleotides
1.4 Global Antisense Oligonucleotides Market by Application
1.4.1 Overview: Global Antisense Oligonucleotides Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Clinic
1.4.4 Others
1.5 Global Antisense Oligonucleotides Market Size & Forecast
1.6 Global Antisense Oligonucleotides Market Size and Forecast by Region
1.6.1 Global Antisense Oligonucleotides Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Antisense Oligonucleotides Market Size by Region, (2018-2029)
1.6.3 North America Antisense Oligonucleotides Market Size and Prospect (2018-2029)
1.6.4 Europe Antisense Oligonucleotides Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Antisense Oligonucleotides Market Size and Prospect (2018-2029)
1.6.6 South America Antisense Oligonucleotides Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Antisense Oligonucleotides Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Ionis Pharmaceuticals
2.1.1 Ionis Pharmaceuticals Details
2.1.2 Ionis Pharmaceuticals Major Business
2.1.3 Ionis Pharmaceuticals Antisense Oligonucleotides Product and Solutions
2.1.4 Ionis Pharmaceuticals Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Ionis Pharmaceuticals Recent Developments and Future Plans
2.2 Sarepta Therapeutics
2.2.1 Sarepta Therapeutics Details
2.2.2 Sarepta Therapeutics Major Business
2.2.3 Sarepta Therapeutics Antisense Oligonucleotides Product and Solutions
2.2.4 Sarepta Therapeutics Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Sarepta Therapeutics Recent Developments and Future Plans
2.3 Biogen
2.3.1 Biogen Details
2.3.2 Biogen Major Business
2.3.3 Biogen Antisense Oligonucleotides Product and Solutions
2.3.4 Biogen Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Biogen Recent Developments and Future Plans
2.4 Alnylam Pharmaceuticals
2.4.1 Alnylam Pharmaceuticals Details
2.4.2 Alnylam Pharmaceuticals Major Business
2.4.3 Alnylam Pharmaceuticals Antisense Oligonucleotides Product and Solutions
2.4.4 Alnylam Pharmaceuticals Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Alnylam Pharmaceuticals Recent Developments and Future Plans
2.5 Antisense Therapeutics
2.5.1 Antisense Therapeutics Details
2.5.2 Antisense Therapeutics Major Business
2.5.3 Antisense Therapeutics Antisense Oligonucleotides Product and Solutions
2.5.4 Antisense Therapeutics Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Antisense Therapeutics Recent Developments and Future Plans
2.6 Isarna Therapeutics
2.6.1 Isarna Therapeutics Details
2.6.2 Isarna Therapeutics Major Business
2.6.3 Isarna Therapeutics Antisense Oligonucleotides Product and Solutions
2.6.4 Isarna Therapeutics Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Isarna Therapeutics Recent Developments and Future Plans
2.7 Arrowhead Pharmaceuticals
2.7.1 Arrowhead Pharmaceuticals Details
2.7.2 Arrowhead Pharmaceuticals Major Business
2.7.3 Arrowhead Pharmaceuticals Antisense Oligonucleotides Product and Solutions
2.7.4 Arrowhead Pharmaceuticals Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Arrowhead Pharmaceuticals Recent Developments and Future Plans
2.8 Atlantic Pharmaceuticals
2.8.1 Atlantic Pharmaceuticals Details
2.8.2 Atlantic Pharmaceuticals Major Business
2.8.3 Atlantic Pharmaceuticals Antisense Oligonucleotides Product and Solutions
2.8.4 Atlantic Pharmaceuticals Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Atlantic Pharmaceuticals Recent Developments and Future Plans
2.9 Enzon Pharmaceuticals
2.9.1 Enzon Pharmaceuticals Details
2.9.2 Enzon Pharmaceuticals Major Business
2.9.3 Enzon Pharmaceuticals Antisense Oligonucleotides Product and Solutions
2.9.4 Enzon Pharmaceuticals Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Enzon Pharmaceuticals Recent Developments and Future Plans
2.10 Bio-Path Holdings
2.10.1 Bio-Path Holdings Details
2.10.2 Bio-Path Holdings Major Business
2.10.3 Bio-Path Holdings Antisense Oligonucleotides Product and Solutions
2.10.4 Bio-Path Holdings Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Bio-Path Holdings Recent Developments and Future Plans
2.11 GlaxoSmithKline
2.11.1 GlaxoSmithKline Details
2.11.2 GlaxoSmithKline Major Business
2.11.3 GlaxoSmithKline Antisense Oligonucleotides Product and Solutions
2.11.4 GlaxoSmithKline Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 GlaxoSmithKline Recent Developments and Future Plans
2.12 Geron
2.12.1 Geron Details
2.12.2 Geron Major Business
2.12.3 Geron Antisense Oligonucleotides Product and Solutions
2.12.4 Geron Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Geron Recent Developments and Future Plans
2.13 ICO Therapeutics
2.13.1 ICO Therapeutics Details
2.13.2 ICO Therapeutics Major Business
2.13.3 ICO Therapeutics Antisense Oligonucleotides Product and Solutions
2.13.4 ICO Therapeutics Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 ICO Therapeutics Recent Developments and Future Plans
2.14 Marina Biotech
2.14.1 Marina Biotech Details
2.14.2 Marina Biotech Major Business
2.14.3 Marina Biotech Antisense Oligonucleotides Product and Solutions
2.14.4 Marina Biotech Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Marina Biotech Recent Developments and Future Plans
2.15 RXi Pharmaceuticals
2.15.1 RXi Pharmaceuticals Details
2.15.2 RXi Pharmaceuticals Major Business
2.15.3 RXi Pharmaceuticals Antisense Oligonucleotides Product and Solutions
2.15.4 RXi Pharmaceuticals Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 RXi Pharmaceuticals Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Antisense Oligonucleotides Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Antisense Oligonucleotides by Company Revenue
3.2.2 Top 3 Antisense Oligonucleotides Players Market Share in 2022
3.2.3 Top 6 Antisense Oligonucleotides Players Market Share in 2022
3.3 Antisense Oligonucleotides Market: Overall Company Footprint Analysis
3.3.1 Antisense Oligonucleotides Market: Region Footprint
3.3.2 Antisense Oligonucleotides Market: Company Product Type Footprint
3.3.3 Antisense Oligonucleotides Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Antisense Oligonucleotides Consumption Value and Market Share by Type (2018-2023)
4.2 Global Antisense Oligonucleotides Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Antisense Oligonucleotides Consumption Value Market Share by Application (2018-2023)
5.2 Global Antisense Oligonucleotides Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Antisense Oligonucleotides Consumption Value by Type (2018-2029)
6.2 North America Antisense Oligonucleotides Consumption Value by Application (2018-2029)
6.3 North America Antisense Oligonucleotides Market Size by Country
6.3.1 North America Antisense Oligonucleotides Consumption Value by Country (2018-2029)
6.3.2 United States Antisense Oligonucleotides Market Size and Forecast (2018-2029)
6.3.3 Canada Antisense Oligonucleotides Market Size and Forecast (2018-2029)
6.3.4 Mexico Antisense Oligonucleotides Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Antisense Oligonucleotides Consumption Value by Type (2018-2029)
7.2 Europe Antisense Oligonucleotides Consumption Value by Application (2018-2029)
7.3 Europe Antisense Oligonucleotides Market Size by Country
7.3.1 Europe Antisense Oligonucleotides Consumption Value by Country (2018-2029)
7.3.2 Germany Antisense Oligonucleotides Market Size and Forecast (2018-2029)
7.3.3 France Antisense Oligonucleotides Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Antisense Oligonucleotides Market Size and Forecast (2018-2029)
7.3.5 Russia Antisense Oligonucleotides Market Size and Forecast (2018-2029)
7.3.6 Italy Antisense Oligonucleotides Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Antisense Oligonucleotides Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Antisense Oligonucleotides Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Antisense Oligonucleotides Market Size by Region
8.3.1 Asia-Pacific Antisense Oligonucleotides Consumption Value by Region (2018-2029)
8.3.2 China Antisense Oligonucleotides Market Size and Forecast (2018-2029)
8.3.3 Japan Antisense Oligonucleotides Market Size and Forecast (2018-2029)
8.3.4 South Korea Antisense Oligonucleotides Market Size and Forecast (2018-2029)
8.3.5 India Antisense Oligonucleotides Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Antisense Oligonucleotides Market Size and Forecast (2018-2029)
8.3.7 Australia Antisense Oligonucleotides Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Antisense Oligonucleotides Consumption Value by Type (2018-2029)
9.2 South America Antisense Oligonucleotides Consumption Value by Application (2018-2029)
9.3 South America Antisense Oligonucleotides Market Size by Country
9.3.1 South America Antisense Oligonucleotides Consumption Value by Country (2018-2029)
9.3.2 Brazil Antisense Oligonucleotides Market Size and Forecast (2018-2029)
9.3.3 Argentina Antisense Oligonucleotides Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Antisense Oligonucleotides Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Antisense Oligonucleotides Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Antisense Oligonucleotides Market Size by Country
10.3.1 Middle East & Africa Antisense Oligonucleotides Consumption Value by Country (2018-2029)
10.3.2 Turkey Antisense Oligonucleotides Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Antisense Oligonucleotides Market Size and Forecast (2018-2029)
10.3.4 UAE Antisense Oligonucleotides Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Antisense Oligonucleotides Market Drivers
11.2 Antisense Oligonucleotides Market Restraints
11.3 Antisense Oligonucleotides Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Antisense Oligonucleotides Industry Chain
12.2 Antisense Oligonucleotides Upstream Analysis
12.3 Antisense Oligonucleotides Midstream Analysis
12.4 Antisense Oligonucleotides Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Antisense Oligonucleotides
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Antisense Oligonucleotides by Type
1.3.1 Overview: Global Antisense Oligonucleotides Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Antisense Oligonucleotides Consumption Value Market Share by Type in 2022
1.3.3 RNA Antisense Oligonucleotides
1.3.4 DNA Antisense Oligonucleotides
1.4 Global Antisense Oligonucleotides Market by Application
1.4.1 Overview: Global Antisense Oligonucleotides Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Clinic
1.4.4 Others
1.5 Global Antisense Oligonucleotides Market Size & Forecast
1.6 Global Antisense Oligonucleotides Market Size and Forecast by Region
1.6.1 Global Antisense Oligonucleotides Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Antisense Oligonucleotides Market Size by Region, (2018-2029)
1.6.3 North America Antisense Oligonucleotides Market Size and Prospect (2018-2029)
1.6.4 Europe Antisense Oligonucleotides Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Antisense Oligonucleotides Market Size and Prospect (2018-2029)
1.6.6 South America Antisense Oligonucleotides Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Antisense Oligonucleotides Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Ionis Pharmaceuticals
2.1.1 Ionis Pharmaceuticals Details
2.1.2 Ionis Pharmaceuticals Major Business
2.1.3 Ionis Pharmaceuticals Antisense Oligonucleotides Product and Solutions
2.1.4 Ionis Pharmaceuticals Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Ionis Pharmaceuticals Recent Developments and Future Plans
2.2 Sarepta Therapeutics
2.2.1 Sarepta Therapeutics Details
2.2.2 Sarepta Therapeutics Major Business
2.2.3 Sarepta Therapeutics Antisense Oligonucleotides Product and Solutions
2.2.4 Sarepta Therapeutics Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Sarepta Therapeutics Recent Developments and Future Plans
2.3 Biogen
2.3.1 Biogen Details
2.3.2 Biogen Major Business
2.3.3 Biogen Antisense Oligonucleotides Product and Solutions
2.3.4 Biogen Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Biogen Recent Developments and Future Plans
2.4 Alnylam Pharmaceuticals
2.4.1 Alnylam Pharmaceuticals Details
2.4.2 Alnylam Pharmaceuticals Major Business
2.4.3 Alnylam Pharmaceuticals Antisense Oligonucleotides Product and Solutions
2.4.4 Alnylam Pharmaceuticals Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Alnylam Pharmaceuticals Recent Developments and Future Plans
2.5 Antisense Therapeutics
2.5.1 Antisense Therapeutics Details
2.5.2 Antisense Therapeutics Major Business
2.5.3 Antisense Therapeutics Antisense Oligonucleotides Product and Solutions
2.5.4 Antisense Therapeutics Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Antisense Therapeutics Recent Developments and Future Plans
2.6 Isarna Therapeutics
2.6.1 Isarna Therapeutics Details
2.6.2 Isarna Therapeutics Major Business
2.6.3 Isarna Therapeutics Antisense Oligonucleotides Product and Solutions
2.6.4 Isarna Therapeutics Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Isarna Therapeutics Recent Developments and Future Plans
2.7 Arrowhead Pharmaceuticals
2.7.1 Arrowhead Pharmaceuticals Details
2.7.2 Arrowhead Pharmaceuticals Major Business
2.7.3 Arrowhead Pharmaceuticals Antisense Oligonucleotides Product and Solutions
2.7.4 Arrowhead Pharmaceuticals Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Arrowhead Pharmaceuticals Recent Developments and Future Plans
2.8 Atlantic Pharmaceuticals
2.8.1 Atlantic Pharmaceuticals Details
2.8.2 Atlantic Pharmaceuticals Major Business
2.8.3 Atlantic Pharmaceuticals Antisense Oligonucleotides Product and Solutions
2.8.4 Atlantic Pharmaceuticals Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Atlantic Pharmaceuticals Recent Developments and Future Plans
2.9 Enzon Pharmaceuticals
2.9.1 Enzon Pharmaceuticals Details
2.9.2 Enzon Pharmaceuticals Major Business
2.9.3 Enzon Pharmaceuticals Antisense Oligonucleotides Product and Solutions
2.9.4 Enzon Pharmaceuticals Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Enzon Pharmaceuticals Recent Developments and Future Plans
2.10 Bio-Path Holdings
2.10.1 Bio-Path Holdings Details
2.10.2 Bio-Path Holdings Major Business
2.10.3 Bio-Path Holdings Antisense Oligonucleotides Product and Solutions
2.10.4 Bio-Path Holdings Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Bio-Path Holdings Recent Developments and Future Plans
2.11 GlaxoSmithKline
2.11.1 GlaxoSmithKline Details
2.11.2 GlaxoSmithKline Major Business
2.11.3 GlaxoSmithKline Antisense Oligonucleotides Product and Solutions
2.11.4 GlaxoSmithKline Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 GlaxoSmithKline Recent Developments and Future Plans
2.12 Geron
2.12.1 Geron Details
2.12.2 Geron Major Business
2.12.3 Geron Antisense Oligonucleotides Product and Solutions
2.12.4 Geron Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Geron Recent Developments and Future Plans
2.13 ICO Therapeutics
2.13.1 ICO Therapeutics Details
2.13.2 ICO Therapeutics Major Business
2.13.3 ICO Therapeutics Antisense Oligonucleotides Product and Solutions
2.13.4 ICO Therapeutics Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 ICO Therapeutics Recent Developments and Future Plans
2.14 Marina Biotech
2.14.1 Marina Biotech Details
2.14.2 Marina Biotech Major Business
2.14.3 Marina Biotech Antisense Oligonucleotides Product and Solutions
2.14.4 Marina Biotech Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Marina Biotech Recent Developments and Future Plans
2.15 RXi Pharmaceuticals
2.15.1 RXi Pharmaceuticals Details
2.15.2 RXi Pharmaceuticals Major Business
2.15.3 RXi Pharmaceuticals Antisense Oligonucleotides Product and Solutions
2.15.4 RXi Pharmaceuticals Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 RXi Pharmaceuticals Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Antisense Oligonucleotides Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Antisense Oligonucleotides by Company Revenue
3.2.2 Top 3 Antisense Oligonucleotides Players Market Share in 2022
3.2.3 Top 6 Antisense Oligonucleotides Players Market Share in 2022
3.3 Antisense Oligonucleotides Market: Overall Company Footprint Analysis
3.3.1 Antisense Oligonucleotides Market: Region Footprint
3.3.2 Antisense Oligonucleotides Market: Company Product Type Footprint
3.3.3 Antisense Oligonucleotides Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Antisense Oligonucleotides Consumption Value and Market Share by Type (2018-2023)
4.2 Global Antisense Oligonucleotides Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Antisense Oligonucleotides Consumption Value Market Share by Application (2018-2023)
5.2 Global Antisense Oligonucleotides Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Antisense Oligonucleotides Consumption Value by Type (2018-2029)
6.2 North America Antisense Oligonucleotides Consumption Value by Application (2018-2029)
6.3 North America Antisense Oligonucleotides Market Size by Country
6.3.1 North America Antisense Oligonucleotides Consumption Value by Country (2018-2029)
6.3.2 United States Antisense Oligonucleotides Market Size and Forecast (2018-2029)
6.3.3 Canada Antisense Oligonucleotides Market Size and Forecast (2018-2029)
6.3.4 Mexico Antisense Oligonucleotides Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Antisense Oligonucleotides Consumption Value by Type (2018-2029)
7.2 Europe Antisense Oligonucleotides Consumption Value by Application (2018-2029)
7.3 Europe Antisense Oligonucleotides Market Size by Country
7.3.1 Europe Antisense Oligonucleotides Consumption Value by Country (2018-2029)
7.3.2 Germany Antisense Oligonucleotides Market Size and Forecast (2018-2029)
7.3.3 France Antisense Oligonucleotides Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Antisense Oligonucleotides Market Size and Forecast (2018-2029)
7.3.5 Russia Antisense Oligonucleotides Market Size and Forecast (2018-2029)
7.3.6 Italy Antisense Oligonucleotides Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Antisense Oligonucleotides Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Antisense Oligonucleotides Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Antisense Oligonucleotides Market Size by Region
8.3.1 Asia-Pacific Antisense Oligonucleotides Consumption Value by Region (2018-2029)
8.3.2 China Antisense Oligonucleotides Market Size and Forecast (2018-2029)
8.3.3 Japan Antisense Oligonucleotides Market Size and Forecast (2018-2029)
8.3.4 South Korea Antisense Oligonucleotides Market Size and Forecast (2018-2029)
8.3.5 India Antisense Oligonucleotides Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Antisense Oligonucleotides Market Size and Forecast (2018-2029)
8.3.7 Australia Antisense Oligonucleotides Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Antisense Oligonucleotides Consumption Value by Type (2018-2029)
9.2 South America Antisense Oligonucleotides Consumption Value by Application (2018-2029)
9.3 South America Antisense Oligonucleotides Market Size by Country
9.3.1 South America Antisense Oligonucleotides Consumption Value by Country (2018-2029)
9.3.2 Brazil Antisense Oligonucleotides Market Size and Forecast (2018-2029)
9.3.3 Argentina Antisense Oligonucleotides Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Antisense Oligonucleotides Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Antisense Oligonucleotides Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Antisense Oligonucleotides Market Size by Country
10.3.1 Middle East & Africa Antisense Oligonucleotides Consumption Value by Country (2018-2029)
10.3.2 Turkey Antisense Oligonucleotides Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Antisense Oligonucleotides Market Size and Forecast (2018-2029)
10.3.4 UAE Antisense Oligonucleotides Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Antisense Oligonucleotides Market Drivers
11.2 Antisense Oligonucleotides Market Restraints
11.3 Antisense Oligonucleotides Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Antisense Oligonucleotides Industry Chain
12.2 Antisense Oligonucleotides Upstream Analysis
12.3 Antisense Oligonucleotides Midstream Analysis
12.4 Antisense Oligonucleotides Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Antisense Oligonucleotides Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Antisense Oligonucleotides Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Antisense Oligonucleotides Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Antisense Oligonucleotides Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Ionis Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 6. Ionis Pharmaceuticals Major Business
Table 7. Ionis Pharmaceuticals Antisense Oligonucleotides Product and Solutions
Table 8. Ionis Pharmaceuticals Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Ionis Pharmaceuticals Recent Developments and Future Plans
Table 10. Sarepta Therapeutics Company Information, Head Office, and Major Competitors
Table 11. Sarepta Therapeutics Major Business
Table 12. Sarepta Therapeutics Antisense Oligonucleotides Product and Solutions
Table 13. Sarepta Therapeutics Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Sarepta Therapeutics Recent Developments and Future Plans
Table 15. Biogen Company Information, Head Office, and Major Competitors
Table 16. Biogen Major Business
Table 17. Biogen Antisense Oligonucleotides Product and Solutions
Table 18. Biogen Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Biogen Recent Developments and Future Plans
Table 20. Alnylam Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 21. Alnylam Pharmaceuticals Major Business
Table 22. Alnylam Pharmaceuticals Antisense Oligonucleotides Product and Solutions
Table 23. Alnylam Pharmaceuticals Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Alnylam Pharmaceuticals Recent Developments and Future Plans
Table 25. Antisense Therapeutics Company Information, Head Office, and Major Competitors
Table 26. Antisense Therapeutics Major Business
Table 27. Antisense Therapeutics Antisense Oligonucleotides Product and Solutions
Table 28. Antisense Therapeutics Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Antisense Therapeutics Recent Developments and Future Plans
Table 30. Isarna Therapeutics Company Information, Head Office, and Major Competitors
Table 31. Isarna Therapeutics Major Business
Table 32. Isarna Therapeutics Antisense Oligonucleotides Product and Solutions
Table 33. Isarna Therapeutics Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Isarna Therapeutics Recent Developments and Future Plans
Table 35. Arrowhead Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 36. Arrowhead Pharmaceuticals Major Business
Table 37. Arrowhead Pharmaceuticals Antisense Oligonucleotides Product and Solutions
Table 38. Arrowhead Pharmaceuticals Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Arrowhead Pharmaceuticals Recent Developments and Future Plans
Table 40. Atlantic Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 41. Atlantic Pharmaceuticals Major Business
Table 42. Atlantic Pharmaceuticals Antisense Oligonucleotides Product and Solutions
Table 43. Atlantic Pharmaceuticals Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Atlantic Pharmaceuticals Recent Developments and Future Plans
Table 45. Enzon Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 46. Enzon Pharmaceuticals Major Business
Table 47. Enzon Pharmaceuticals Antisense Oligonucleotides Product and Solutions
Table 48. Enzon Pharmaceuticals Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Enzon Pharmaceuticals Recent Developments and Future Plans
Table 50. Bio-Path Holdings Company Information, Head Office, and Major Competitors
Table 51. Bio-Path Holdings Major Business
Table 52. Bio-Path Holdings Antisense Oligonucleotides Product and Solutions
Table 53. Bio-Path Holdings Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Bio-Path Holdings Recent Developments and Future Plans
Table 55. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 56. GlaxoSmithKline Major Business
Table 57. GlaxoSmithKline Antisense Oligonucleotides Product and Solutions
Table 58. GlaxoSmithKline Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. GlaxoSmithKline Recent Developments and Future Plans
Table 60. Geron Company Information, Head Office, and Major Competitors
Table 61. Geron Major Business
Table 62. Geron Antisense Oligonucleotides Product and Solutions
Table 63. Geron Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Geron Recent Developments and Future Plans
Table 65. ICO Therapeutics Company Information, Head Office, and Major Competitors
Table 66. ICO Therapeutics Major Business
Table 67. ICO Therapeutics Antisense Oligonucleotides Product and Solutions
Table 68. ICO Therapeutics Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. ICO Therapeutics Recent Developments and Future Plans
Table 70. Marina Biotech Company Information, Head Office, and Major Competitors
Table 71. Marina Biotech Major Business
Table 72. Marina Biotech Antisense Oligonucleotides Product and Solutions
Table 73. Marina Biotech Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Marina Biotech Recent Developments and Future Plans
Table 75. RXi Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 76. RXi Pharmaceuticals Major Business
Table 77. RXi Pharmaceuticals Antisense Oligonucleotides Product and Solutions
Table 78. RXi Pharmaceuticals Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. RXi Pharmaceuticals Recent Developments and Future Plans
Table 80. Global Antisense Oligonucleotides Revenue (USD Million) by Players (2018-2023)
Table 81. Global Antisense Oligonucleotides Revenue Share by Players (2018-2023)
Table 82. Breakdown of Antisense Oligonucleotides by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in Antisense Oligonucleotides, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 84. Head Office of Key Antisense Oligonucleotides Players
Table 85. Antisense Oligonucleotides Market: Company Product Type Footprint
Table 86. Antisense Oligonucleotides Market: Company Product Application Footprint
Table 87. Antisense Oligonucleotides New Market Entrants and Barriers to Market Entry
Table 88. Antisense Oligonucleotides Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Antisense Oligonucleotides Consumption Value (USD Million) by Type (2018-2023)
Table 90. Global Antisense Oligonucleotides Consumption Value Share by Type (2018-2023)
Table 91. Global Antisense Oligonucleotides Consumption Value Forecast by Type (2024-2029)
Table 92. Global Antisense Oligonucleotides Consumption Value by Application (2018-2023)
Table 93. Global Antisense Oligonucleotides Consumption Value Forecast by Application (2024-2029)
Table 94. North America Antisense Oligonucleotides Consumption Value by Type (2018-2023) & (USD Million)
Table 95. North America Antisense Oligonucleotides Consumption Value by Type (2024-2029) & (USD Million)
Table 96. North America Antisense Oligonucleotides Consumption Value by Application (2018-2023) & (USD Million)
Table 97. North America Antisense Oligonucleotides Consumption Value by Application (2024-2029) & (USD Million)
Table 98. North America Antisense Oligonucleotides Consumption Value by Country (2018-2023) & (USD Million)
Table 99. North America Antisense Oligonucleotides Consumption Value by Country (2024-2029) & (USD Million)
Table 100. Europe Antisense Oligonucleotides Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Europe Antisense Oligonucleotides Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Europe Antisense Oligonucleotides Consumption Value by Application (2018-2023) & (USD Million)
Table 103. Europe Antisense Oligonucleotides Consumption Value by Application (2024-2029) & (USD Million)
Table 104. Europe Antisense Oligonucleotides Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Antisense Oligonucleotides Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Antisense Oligonucleotides Consumption Value by Type (2018-2023) & (USD Million)
Table 107. Asia-Pacific Antisense Oligonucleotides Consumption Value by Type (2024-2029) & (USD Million)
Table 108. Asia-Pacific Antisense Oligonucleotides Consumption Value by Application (2018-2023) & (USD Million)
Table 109. Asia-Pacific Antisense Oligonucleotides Consumption Value by Application (2024-2029) & (USD Million)
Table 110. Asia-Pacific Antisense Oligonucleotides Consumption Value by Region (2018-2023) & (USD Million)
Table 111. Asia-Pacific Antisense Oligonucleotides Consumption Value by Region (2024-2029) & (USD Million)
Table 112. South America Antisense Oligonucleotides Consumption Value by Type (2018-2023) & (USD Million)
Table 113. South America Antisense Oligonucleotides Consumption Value by Type (2024-2029) & (USD Million)
Table 114. South America Antisense Oligonucleotides Consumption Value by Application (2018-2023) & (USD Million)
Table 115. South America Antisense Oligonucleotides Consumption Value by Application (2024-2029) & (USD Million)
Table 116. South America Antisense Oligonucleotides Consumption Value by Country (2018-2023) & (USD Million)
Table 117. South America Antisense Oligonucleotides Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Middle East & Africa Antisense Oligonucleotides Consumption Value by Type (2018-2023) & (USD Million)
Table 119. Middle East & Africa Antisense Oligonucleotides Consumption Value by Type (2024-2029) & (USD Million)
Table 120. Middle East & Africa Antisense Oligonucleotides Consumption Value by Application (2018-2023) & (USD Million)
Table 121. Middle East & Africa Antisense Oligonucleotides Consumption Value by Application (2024-2029) & (USD Million)
Table 122. Middle East & Africa Antisense Oligonucleotides Consumption Value by Country (2018-2023) & (USD Million)
Table 123. Middle East & Africa Antisense Oligonucleotides Consumption Value by Country (2024-2029) & (USD Million)
Table 124. Antisense Oligonucleotides Raw Material
Table 125. Key Suppliers of Antisense Oligonucleotides Raw Materials
Table 1. Global Antisense Oligonucleotides Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Antisense Oligonucleotides Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Antisense Oligonucleotides Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Antisense Oligonucleotides Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Ionis Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 6. Ionis Pharmaceuticals Major Business
Table 7. Ionis Pharmaceuticals Antisense Oligonucleotides Product and Solutions
Table 8. Ionis Pharmaceuticals Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Ionis Pharmaceuticals Recent Developments and Future Plans
Table 10. Sarepta Therapeutics Company Information, Head Office, and Major Competitors
Table 11. Sarepta Therapeutics Major Business
Table 12. Sarepta Therapeutics Antisense Oligonucleotides Product and Solutions
Table 13. Sarepta Therapeutics Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Sarepta Therapeutics Recent Developments and Future Plans
Table 15. Biogen Company Information, Head Office, and Major Competitors
Table 16. Biogen Major Business
Table 17. Biogen Antisense Oligonucleotides Product and Solutions
Table 18. Biogen Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Biogen Recent Developments and Future Plans
Table 20. Alnylam Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 21. Alnylam Pharmaceuticals Major Business
Table 22. Alnylam Pharmaceuticals Antisense Oligonucleotides Product and Solutions
Table 23. Alnylam Pharmaceuticals Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Alnylam Pharmaceuticals Recent Developments and Future Plans
Table 25. Antisense Therapeutics Company Information, Head Office, and Major Competitors
Table 26. Antisense Therapeutics Major Business
Table 27. Antisense Therapeutics Antisense Oligonucleotides Product and Solutions
Table 28. Antisense Therapeutics Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Antisense Therapeutics Recent Developments and Future Plans
Table 30. Isarna Therapeutics Company Information, Head Office, and Major Competitors
Table 31. Isarna Therapeutics Major Business
Table 32. Isarna Therapeutics Antisense Oligonucleotides Product and Solutions
Table 33. Isarna Therapeutics Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Isarna Therapeutics Recent Developments and Future Plans
Table 35. Arrowhead Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 36. Arrowhead Pharmaceuticals Major Business
Table 37. Arrowhead Pharmaceuticals Antisense Oligonucleotides Product and Solutions
Table 38. Arrowhead Pharmaceuticals Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Arrowhead Pharmaceuticals Recent Developments and Future Plans
Table 40. Atlantic Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 41. Atlantic Pharmaceuticals Major Business
Table 42. Atlantic Pharmaceuticals Antisense Oligonucleotides Product and Solutions
Table 43. Atlantic Pharmaceuticals Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Atlantic Pharmaceuticals Recent Developments and Future Plans
Table 45. Enzon Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 46. Enzon Pharmaceuticals Major Business
Table 47. Enzon Pharmaceuticals Antisense Oligonucleotides Product and Solutions
Table 48. Enzon Pharmaceuticals Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Enzon Pharmaceuticals Recent Developments and Future Plans
Table 50. Bio-Path Holdings Company Information, Head Office, and Major Competitors
Table 51. Bio-Path Holdings Major Business
Table 52. Bio-Path Holdings Antisense Oligonucleotides Product and Solutions
Table 53. Bio-Path Holdings Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Bio-Path Holdings Recent Developments and Future Plans
Table 55. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 56. GlaxoSmithKline Major Business
Table 57. GlaxoSmithKline Antisense Oligonucleotides Product and Solutions
Table 58. GlaxoSmithKline Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. GlaxoSmithKline Recent Developments and Future Plans
Table 60. Geron Company Information, Head Office, and Major Competitors
Table 61. Geron Major Business
Table 62. Geron Antisense Oligonucleotides Product and Solutions
Table 63. Geron Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Geron Recent Developments and Future Plans
Table 65. ICO Therapeutics Company Information, Head Office, and Major Competitors
Table 66. ICO Therapeutics Major Business
Table 67. ICO Therapeutics Antisense Oligonucleotides Product and Solutions
Table 68. ICO Therapeutics Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. ICO Therapeutics Recent Developments and Future Plans
Table 70. Marina Biotech Company Information, Head Office, and Major Competitors
Table 71. Marina Biotech Major Business
Table 72. Marina Biotech Antisense Oligonucleotides Product and Solutions
Table 73. Marina Biotech Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Marina Biotech Recent Developments and Future Plans
Table 75. RXi Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 76. RXi Pharmaceuticals Major Business
Table 77. RXi Pharmaceuticals Antisense Oligonucleotides Product and Solutions
Table 78. RXi Pharmaceuticals Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. RXi Pharmaceuticals Recent Developments and Future Plans
Table 80. Global Antisense Oligonucleotides Revenue (USD Million) by Players (2018-2023)
Table 81. Global Antisense Oligonucleotides Revenue Share by Players (2018-2023)
Table 82. Breakdown of Antisense Oligonucleotides by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in Antisense Oligonucleotides, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 84. Head Office of Key Antisense Oligonucleotides Players
Table 85. Antisense Oligonucleotides Market: Company Product Type Footprint
Table 86. Antisense Oligonucleotides Market: Company Product Application Footprint
Table 87. Antisense Oligonucleotides New Market Entrants and Barriers to Market Entry
Table 88. Antisense Oligonucleotides Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Antisense Oligonucleotides Consumption Value (USD Million) by Type (2018-2023)
Table 90. Global Antisense Oligonucleotides Consumption Value Share by Type (2018-2023)
Table 91. Global Antisense Oligonucleotides Consumption Value Forecast by Type (2024-2029)
Table 92. Global Antisense Oligonucleotides Consumption Value by Application (2018-2023)
Table 93. Global Antisense Oligonucleotides Consumption Value Forecast by Application (2024-2029)
Table 94. North America Antisense Oligonucleotides Consumption Value by Type (2018-2023) & (USD Million)
Table 95. North America Antisense Oligonucleotides Consumption Value by Type (2024-2029) & (USD Million)
Table 96. North America Antisense Oligonucleotides Consumption Value by Application (2018-2023) & (USD Million)
Table 97. North America Antisense Oligonucleotides Consumption Value by Application (2024-2029) & (USD Million)
Table 98. North America Antisense Oligonucleotides Consumption Value by Country (2018-2023) & (USD Million)
Table 99. North America Antisense Oligonucleotides Consumption Value by Country (2024-2029) & (USD Million)
Table 100. Europe Antisense Oligonucleotides Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Europe Antisense Oligonucleotides Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Europe Antisense Oligonucleotides Consumption Value by Application (2018-2023) & (USD Million)
Table 103. Europe Antisense Oligonucleotides Consumption Value by Application (2024-2029) & (USD Million)
Table 104. Europe Antisense Oligonucleotides Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Antisense Oligonucleotides Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Antisense Oligonucleotides Consumption Value by Type (2018-2023) & (USD Million)
Table 107. Asia-Pacific Antisense Oligonucleotides Consumption Value by Type (2024-2029) & (USD Million)
Table 108. Asia-Pacific Antisense Oligonucleotides Consumption Value by Application (2018-2023) & (USD Million)
Table 109. Asia-Pacific Antisense Oligonucleotides Consumption Value by Application (2024-2029) & (USD Million)
Table 110. Asia-Pacific Antisense Oligonucleotides Consumption Value by Region (2018-2023) & (USD Million)
Table 111. Asia-Pacific Antisense Oligonucleotides Consumption Value by Region (2024-2029) & (USD Million)
Table 112. South America Antisense Oligonucleotides Consumption Value by Type (2018-2023) & (USD Million)
Table 113. South America Antisense Oligonucleotides Consumption Value by Type (2024-2029) & (USD Million)
Table 114. South America Antisense Oligonucleotides Consumption Value by Application (2018-2023) & (USD Million)
Table 115. South America Antisense Oligonucleotides Consumption Value by Application (2024-2029) & (USD Million)
Table 116. South America Antisense Oligonucleotides Consumption Value by Country (2018-2023) & (USD Million)
Table 117. South America Antisense Oligonucleotides Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Middle East & Africa Antisense Oligonucleotides Consumption Value by Type (2018-2023) & (USD Million)
Table 119. Middle East & Africa Antisense Oligonucleotides Consumption Value by Type (2024-2029) & (USD Million)
Table 120. Middle East & Africa Antisense Oligonucleotides Consumption Value by Application (2018-2023) & (USD Million)
Table 121. Middle East & Africa Antisense Oligonucleotides Consumption Value by Application (2024-2029) & (USD Million)
Table 122. Middle East & Africa Antisense Oligonucleotides Consumption Value by Country (2018-2023) & (USD Million)
Table 123. Middle East & Africa Antisense Oligonucleotides Consumption Value by Country (2024-2029) & (USD Million)
Table 124. Antisense Oligonucleotides Raw Material
Table 125. Key Suppliers of Antisense Oligonucleotides Raw Materials
LIST OF FIGURES
Figure 1. Antisense Oligonucleotides Picture
Figure 2. Global Antisense Oligonucleotides Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Antisense Oligonucleotides Consumption Value Market Share by Type in 2022
Figure 4. RNA Antisense Oligonucleotides
Figure 5. DNA Antisense Oligonucleotides
Figure 6. Global Antisense Oligonucleotides Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Antisense Oligonucleotides Consumption Value Market Share by Application in 2022
Figure 8. Hospitals Picture
Figure 9. Clinic Picture
Figure 10. Others Picture
Figure 11. Global Antisense Oligonucleotides Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Antisense Oligonucleotides Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Antisense Oligonucleotides Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Antisense Oligonucleotides Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Antisense Oligonucleotides Consumption Value Market Share by Region in 2022
Figure 16. North America Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Antisense Oligonucleotides Revenue Share by Players in 2022
Figure 22. Antisense Oligonucleotides Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Antisense Oligonucleotides Market Share in 2022
Figure 24. Global Top 6 Players Antisense Oligonucleotides Market Share in 2022
Figure 25. Global Antisense Oligonucleotides Consumption Value Share by Type (2018-2023)
Figure 26. Global Antisense Oligonucleotides Market Share Forecast by Type (2024-2029)
Figure 27. Global Antisense Oligonucleotides Consumption Value Share by Application (2018-2023)
Figure 28. Global Antisense Oligonucleotides Market Share Forecast by Application (2024-2029)
Figure 29. North America Antisense Oligonucleotides Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Antisense Oligonucleotides Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Antisense Oligonucleotides Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Antisense Oligonucleotides Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Antisense Oligonucleotides Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Antisense Oligonucleotides Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 39. France Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Antisense Oligonucleotides Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Antisense Oligonucleotides Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Antisense Oligonucleotides Consumption Value Market Share by Region (2018-2029)
Figure 46. China Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 49. India Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Antisense Oligonucleotides Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Antisense Oligonucleotides Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Antisense Oligonucleotides Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Antisense Oligonucleotides Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Antisense Oligonucleotides Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Antisense Oligonucleotides Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 63. Antisense Oligonucleotides Market Drivers
Figure 64. Antisense Oligonucleotides Market Restraints
Figure 65. Antisense Oligonucleotides Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Antisense Oligonucleotides in 2022
Figure 68. Manufacturing Process Analysis of Antisense Oligonucleotides
Figure 69. Antisense Oligonucleotides Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Antisense Oligonucleotides Picture
Figure 2. Global Antisense Oligonucleotides Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Antisense Oligonucleotides Consumption Value Market Share by Type in 2022
Figure 4. RNA Antisense Oligonucleotides
Figure 5. DNA Antisense Oligonucleotides
Figure 6. Global Antisense Oligonucleotides Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Antisense Oligonucleotides Consumption Value Market Share by Application in 2022
Figure 8. Hospitals Picture
Figure 9. Clinic Picture
Figure 10. Others Picture
Figure 11. Global Antisense Oligonucleotides Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Antisense Oligonucleotides Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Antisense Oligonucleotides Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Antisense Oligonucleotides Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Antisense Oligonucleotides Consumption Value Market Share by Region in 2022
Figure 16. North America Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Antisense Oligonucleotides Revenue Share by Players in 2022
Figure 22. Antisense Oligonucleotides Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Antisense Oligonucleotides Market Share in 2022
Figure 24. Global Top 6 Players Antisense Oligonucleotides Market Share in 2022
Figure 25. Global Antisense Oligonucleotides Consumption Value Share by Type (2018-2023)
Figure 26. Global Antisense Oligonucleotides Market Share Forecast by Type (2024-2029)
Figure 27. Global Antisense Oligonucleotides Consumption Value Share by Application (2018-2023)
Figure 28. Global Antisense Oligonucleotides Market Share Forecast by Application (2024-2029)
Figure 29. North America Antisense Oligonucleotides Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Antisense Oligonucleotides Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Antisense Oligonucleotides Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Antisense Oligonucleotides Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Antisense Oligonucleotides Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Antisense Oligonucleotides Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 39. France Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Antisense Oligonucleotides Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Antisense Oligonucleotides Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Antisense Oligonucleotides Consumption Value Market Share by Region (2018-2029)
Figure 46. China Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 49. India Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Antisense Oligonucleotides Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Antisense Oligonucleotides Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Antisense Oligonucleotides Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Antisense Oligonucleotides Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Antisense Oligonucleotides Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Antisense Oligonucleotides Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
Figure 63. Antisense Oligonucleotides Market Drivers
Figure 64. Antisense Oligonucleotides Market Restraints
Figure 65. Antisense Oligonucleotides Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Antisense Oligonucleotides in 2022
Figure 68. Manufacturing Process Analysis of Antisense Oligonucleotides
Figure 69. Antisense Oligonucleotides Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
